ArthroCare Corporation(ARTC)- NASDAQ
ARTC is defunct.
  • Feb. 3, 2014, 9:09 AM
    | Feb. 3, 2014, 9:09 AM | 8 Comments
  • Jan. 8, 2014, 12:46 PM
    | Jan. 8, 2014, 12:46 PM | 2 Comments
  • Jan. 7, 2014, 6:16 PM
    • ArthroCare (ARTC) +10.9% AH enters into a deferred prosecution agreement with the Justice Department which resolves the DOJ investigation regarding allegations of securities and related fraud committed under a previous management team.
    • As part of the agreement, ARTC will pay a $30M fine to the DOJ and maintain a compliance program that it must report on annually.
    | Jan. 7, 2014, 6:16 PM
  • Aug. 5, 2013, 4:17 PM
    • ArthroCare (ARTC): Q2 EPS of -$0.27.
    • Revenue of $92.1M misses by $1.57M. Shares +6.1% AH. (PR)
    | Aug. 5, 2013, 4:17 PM
  • Feb. 17, 2012, 2:10 PM

    Arthrocare (ARTC -17.8%) shares plunges a day after reporting a substantial Q4 loss attributed largely to hefty charges related to a proposed settlement of certain securities class action suits. Jefferies cuts its stock rating to Hold from Buy and drops its price target to $25 from $32, citing the "new and entirely unexpected" investigation which will preclude an anticipated takeover.

    | Feb. 17, 2012, 2:10 PM
  • Nov. 28, 2011, 10:47 AM

    ArthroCare (ARTC) tacks on a 9.4% gain after announcing a $74M agreement to settle a class action lawsuit pending against the medical devices firm in relation to securities transactions between Dec. 11, 2007 and Feb. 18, 2009.

    | Nov. 28, 2011, 10:47 AM
Company Description
ArthroCare Corporation develops, manufactures and markets minimally invasive surgical products, many of which are based on its patented Coblation(r) technology. The Company's business consists of two core product areas: Sports Medicine and ENT.
Sector: Healthcare
Industry: Medical Appliances & Equipment
Country: United States